NCT01747941View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy
Interventions
DRUG

PF-06305591

single dose, solution

DRUG

Placebo

matching placebo

DRUG

PF-06305591

single dose, solution

DRUG

Placebo

matching placebo

DRUG

PF-06305591

single dose, solution

DRUG

Placebo

matching placebo

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01747941 - Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter